Clinical Trials Logo

Unrecognized Condition clinical trials

View clinical trials related to Unrecognized Condition.

Filter by:

NCT ID: NCT05132608 Completed - Clinical trials for Unrecognized Condition

Effect of a Social Media-based Health Education Program on Postnatal Care (PNC) Knowledge Among Pregnant Women Using Smartphones in Dhulikhel Hospital

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Its an interventional study conducted to assess the effect of social media-based health education program on PNC knowledge among pregnant women attending Dhulikhel hospital, Nepal.

NCT ID: NCT04995549 Completed - Clinical trials for Unrecognized Condition

SKin Uncertainties Modeling

SKUM
Start date: November 26, 2021
Phase: N/A
Study type: Interventional

The study is based on measurement device and will provide a database of viscoelastic properties of the forearm skin among healthy volunteers. These data will be used to develop a mathematical model representative of the mechanical behavior of the skin.

NCT ID: NCT04931316 Recruiting - Clinical trials for Unrecognized Condition

Incidence and Management of Ocular Hypertension Following Deep Anterior Lamellar Keratoplasty

Dalk
Start date: March 15, 2021
Phase:
Study type: Observational

This is a retrospective case series study that included patients who performed deep anterior lamellar keratoplasty and presented with elevated intraocular pressure during follow up.

NCT ID: NCT04846062 Not yet recruiting - Clinical trials for Unrecognized Condition

Nutrition Behavior on Micronutrient Among Growth Children in Central Highland of Ethiopia: Cluster Randomized Trial.

Start date: April 15, 2021
Phase: N/A
Study type: Interventional

Hypotheses of the study 1. Mothers/ caregivers who have less knowledge and attitude about the prevention of IDD their table salt obtained from in the households has less quantity of iodide than those mothers/ caregivers who might have knowledge and attitude. 2. Mothers/ caregivers with poor knowledge and attitude in iodized salt utilization circumstances that their index children have at higher risk of iodine deficiency compared with their properly utilizes counterparts. linear 3. Children's poor dietary intake has low hemoglobin concentration compared to their peers who used diversified dietary intake. 4. Children with a low concentration of iodine have stunted growth (linear growth) compared with their high iodine concentration peers at the end of the follow-up period of fifteen months. 5. Children with a low concentration of hemoglobin have stunted growth (linear growth) compared with their high hemoglobin concentration peers at the end of the follow-up fifteen months. 6. Higher concentrations of micronutrients due affect the growth of children compared with their higher concentration of micronutrients at the end of the follow-up period of fifteen months.

NCT ID: NCT04299698 Completed - Clinical trials for Unrecognized Condition

Interaction of Genetic and Environmental Factors for Body Fat Mass Control

Start date: June 7, 2017
Phase:
Study type: Observational

Although the effect of interaction between genetic and environmental factors on body fat mass (BFM) has been proposed, how lifestyle changes affect body weight with regard to the genetic composition needs to be verified. The investigators designed an observational study, consisting of healthy adults with single nucleotide polymorphism (SNP) genotyping and longitudinal monitoring of lifestyle including food consumption and physical activities. The investigators recruited the participants who desired to control their body fat mass. Participants freely choose one of the options among carbohydrate intake reduction, fat intake reduction or exercise amount increment to control their body fat mass. Their lifelog on exercise and diet were collected, using a wearable device, for three months. Further, the investigators assessed anthropometric and serologic markers to measure the effect of participant's lifestyle modification. The investigators evaluate the influence of genetic compositions on body fat reduction induced by lifestyle change. Four different genome-wide polygenic scores (GPS) of volunteers are calculated to test the genetic effects of each modification. In this lifestyle observational study, the investigators expect to validate the interaction of genetic and environmental factors in determining BFM, and implicate the healthcare utility of lifestyle modifications using personalized and genomic perspective.

NCT ID: NCT04213612 Not yet recruiting - Clinical trials for Unrecognized Condition

DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors

Start date: December 30, 2019
Phase: Phase 1
Study type: Interventional

Doxorubicin is an anthracycline antibiotic that is part of the standard treatment for many pediatric malignancies, but its long-term cardiotoxicity cannot be ignored. Without affecting overall survival, in order to improve the quality of life of childhood tumor survivors and reduce cardiotoxicity, drugs with less cardiotoxicity should be selected; compared with ordinary doxorubicin, PEGylated doxorubicin (PLD ) The biggest advantage is the low cardiotoxicity. PEGylated doxorubicin (Caelyx®) has undergone a Phase I dose climbing clinical trial in children with solid tumors. The drug is safe by testing PK. The results of Phase II clinical studies of Caelyx® in children with progressive soft tissue sarcoma show that the drug is safe. Domestically produced PEGylated doxorubicin has no data on childhood tumors in China. Therefore, we plan to conduct a phase I study in pediatric solid tumors of pegylated doxorubicin combined with cyclophosphamide, vincristine, relapsed, and refractory childhood solid tumors. Maximum tolerated dose and effectiveness of stellate in children with solid tumors, thus laying the foundation for future phase II / III clinical studies

NCT ID: NCT04102813 Completed - Clinical trials for Unrecognized Condition

Deep Diaphragmatic Breathing: Neurobiological and Anti-inflammatory Effects

Start date: February 24, 2020
Phase: N/A
Study type: Interventional

The exposure to acute and\or chronic stress can produce an activation of sympathetic nervous system (SNS), leading to an increased level of cortisol and pro-inflammatory cytokines. The mind-body techniques (MBT), such as diaphragmatic breathing, mindfulness, and Yoga, have demonstrated their validity in reducing mental stress and relieving inflammatory conditions. The aim of our study is to verify the efficacy of a single Functional Therapy (FT) session to relieve inflammations, decreasing cortisol levels and activating the parasympathetic nervous system in healthy subjects after the administration of an acute stress such as the Trier Social Stress Test (TSST) protocol. After a psychiatric, psychological and anthropometric assessment, participants are randomly assigned to FT or attention placebo control group. The FT session lasting for 30 minutes and is conducted by therapists specialized in the MBT. The treatment's efficacy in reducing inflammatory states is verified by measuring the variations of the hearth rate, skin conductance, electromyography, pro-inflammatory cytokines (IL-6, TNFα, IL1β), anti-inflammatory cytokine (IL-10), and salivary cortisol; furthermore, the State Trait Anxiety Inventory (STAI) (state and trait) and Subjective Units of Distress Scale (SUDS) questionnaires are used as psychometric measures of anxiety and stress. All the participants are tested at baseline, at the end of TSST, at the end of the FT or audiobook session, and at follow-up 30 minutes after the session.

NCT ID: NCT03766646 Completed - Clinical trials for Unrecognized Condition

Preoxygenation With Optiflow™ - the Effect of Speech on Lung Oxygenation.

Start date: October 18, 2018
Phase: N/A
Study type: Interventional

If a patient speaks during the process of preoxygenation with high-flow nasal oxygen via the Optiflow™ system, is the efficacy reduced as measured by end-tidal lung oxygen content?

NCT ID: NCT03477071 Completed - Clinical trials for Unrecognized Condition

A 15-year Single Center Experience of Endovascular Treatment of Transplant Renal Artery Stenosis

Start date: January 1, 2010
Phase:
Study type: Observational

Stenosis of the renal graft arteries occurs in 1 to 26% of cases and can damage the graft. Endovascular treatment is first-line treatment. The main objective of this study is to identify the predictive factors of failure of peri-anastomotic.

NCT ID: NCT03445442 Completed - Clinical trials for Unrecognized Condition

Different Surgical Techniques Used for Prolapse Repair in Elderly Patient

Start date: January 1, 2011
Phase:
Study type: Observational

The investigator aimed to compare various pelvic floor repairs in female aged from 70 to 80 years old, to see which procedure in terms of treatment-related complications of SCP, VMR and NTR by comparing the operative and functional outcomes in this patient population.